The business was discontinued 4 months ago because BGI had issued a „birth certificate“ which was not covered by SFDA regulations. In the meantime, permission was granted and sequencing covers fetal chromosomal aneuploidy (T 21, T 18, T 13).
China Bio news release, July 3, 2014